🇲🇾 Country Profile

Malaysia

Expanding pharmaceutical supply to Malaysia

🇲🇾 $170M
All data from DGCIS India export records (fiscal year, April–March).
$170M
Scale
Malaysia's healthcare system receives $170M in Indian pharmaceutical products each year, affordable, quality medicine.
74%
Medicine
Primarily medicines (74%), supplemented by medicine ingredients and surgical & hospital supplies.
2.2×
Trajectory
India's pharmaceutical supply to Malaysia has grown 2.2× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Malaysia, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $125M (73.6%) Medicine Ingredients $29.3M (17.2%) Surgical & Hospital Supplies $8.1M (4.8%) Traditional & Herbal $4.9M (2.9%) Vaccines $2.5M (1.5%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Malaysia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Malaysia: $800M across 29 filings (2011-2025).